These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12547044)

  • 1. Efficacy of gelclair in reducing pain in palliative care patients with oral lesions: preliminary findings from an open pilot study.
    Innocenti M; Moscatelli G; Lopez S
    J Pain Symptom Manage; 2002 Nov; 24(5):456-7. PubMed ID: 12547044
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparing pain control and ability to eat and drink with standard therapy vs Gelclair: a preliminary, double centre, randomised controlled trial on patients with radiotherapy-induced oral mucositis.
    Barber C; Powell R; Ellis A; Hewett J
    Support Care Cancer; 2007 Apr; 15(4):427-40. PubMed ID: 17131132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gelclair: managing the symptoms of oral mucositis.
    Smith T
    Hosp Med; 2001 Oct; 62(10):623-6. PubMed ID: 11688125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical effectiveness of Gelclair in the management of oral mucositis.
    Aust Nurs J; 2009 Apr; 16(9):30-3. PubMed ID: 19437954
    [No Abstract]   [Full Text] [Related]  

  • 5. Polyvinylpyrrolidone-sodium hyaluronate gel (Gelclair): a bioadherent oral gel for the treatment of oral mucositis and other painful oral lesions.
    Buchsel PC
    Expert Opin Drug Metab Toxicol; 2008 Nov; 4(11):1449-54. PubMed ID: 18950285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gelclair oral gel.
    Buchsel PC
    Clin J Oncol Nurs; 2003; 7(1):109-10. PubMed ID: 12629946
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of polyvinylpyrrolidone-sodium hyaluronate gel (Gelclair) on oral microbial colonization and pain control compared with other rinsing solutions in patients with oral mucositis after allogeneic stem cells transplantation.
    Vokurka S; Skardova J; Hruskova R; Kabatova-Maxova K; Svoboda T; Bystricka E; Steinerova K; Koza V
    Med Sci Monit; 2011 Oct; 17(10):CR572-6. PubMed ID: 21959611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessing the effectiveness of Gelclair® in the prevention and therapy of stomatitis in patients undergoing hematopoietic stem-cell transplantation: a randomized trial].
    Rasero L; Marsullo M; Dal Molin A
    Prof Inferm; 2014; 67(1):15-20. PubMed ID: 24762768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the clinical behaviour of a polyvinylpyrrolidone and sodium hyalonurate gel (Gelclair) in patients subjected to surgical treatment with CO2 laser.
    Hita-Iglesias P; Torres-Lagares D; Gutiérrez-Pérez JL
    Int J Oral Maxillofac Surg; 2006 Jun; 35(6):514-7. PubMed ID: 16497479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current developments in treating chemotherapy-related oral mucositis.
    Epstein J
    Clin Adv Hematol Oncol; 2003 Dec; 1(12):712-3. PubMed ID: 16258473
    [No Abstract]   [Full Text] [Related]  

  • 11. Advancing the assessment and treatment of mucositis.
    ONS News; 2004; 19(9 Suppl):39-40. PubMed ID: 15478580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Breakthrough pain--analysis and therapy. A pilot study of a new drug, transmucosal fentanyl (Actiq)].
    Johansson H; Arnér S
    Lakartidningen; 2004 Feb; 101(7):552-4. PubMed ID: 15024861
    [No Abstract]   [Full Text] [Related]  

  • 13. Potential utility of the peripheral analgesic properties of morphine in stomatitis-related pain: a pilot study.
    Cerchietti LC; Navigante AH; Körte MW; Cohen AM; Quiroga PN; Villaamil EC; Bonomi MR; Roth BM
    Pain; 2003 Sep; 105(1-2):265-73. PubMed ID: 14499444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption of fentanyl from fentanyl buccal tablet in cancer patients with or without oral mucositis: a pilot study.
    Darwish M; Kirby M; Robertson P; Tracewell W; Jiang JG
    Clin Drug Investig; 2007; 27(9):605-11. PubMed ID: 17705569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anesthetic and medicated ointments].
    Grasser H; Ackermann K
    Zahnarztl Prax; 1974 Oct; 25(19):455-6. PubMed ID: 4533854
    [No Abstract]   [Full Text] [Related]  

  • 16. The treatment of oral problems in the palliative patient.
    Wiseman M
    J Can Dent Assoc; 2006 Jun; 72(5):453-8. PubMed ID: 16772071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promising new approaches to managing mucositis.
    J Support Oncol; 2003; 1(4):245, 278. PubMed ID: 15334866
    [No Abstract]   [Full Text] [Related]  

  • 18. The total challenge of cancer pain in supportive and palliative care.
    Ahmedzai SH; Boland J
    Curr Opin Support Palliat Care; 2007 Apr; 1(1):3-5. PubMed ID: 18660716
    [No Abstract]   [Full Text] [Related]  

  • 19. Tolerability and effects of two formulations of oral transmucosal fentanyl citrate (OTFC; ACTIQ) in patients with radiation-induced oral mucositis.
    Shaiova L; Lapin J; Manco LS; Shasha D; Hu K; Harrison L; Portenoy RK
    Support Care Cancer; 2004 Apr; 12(4):268-73. PubMed ID: 14750002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating cancer-related breakthrough pain: the oral transmucosal route.
    Laverty D
    Int J Palliat Nurs; 2007 Jul; 13(7):326-31. PubMed ID: 17851376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.